Janus Henderson Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $72.2K | Buy |
|
|||||
|
2023
Q2 | $161K | Buy |
|
|||||
|
2023
Q1 | $194K | Buy |
|
|||||
|
2022
Q4 | $156K | Sell |
|
|||||
|
2022
Q3 | $63.9M | Buy |
|
|||||
|
2022
Q2 | $35.6M | Sell |
|
|||||
|
2022
Q1 | $57M | Sell |
|
|||||
|
2021
Q4 | $90.3M | Sell |
|
|||||
|
2021
Q3 | $102M | Sell |
|
|||||
|
2021
Q2 | $158M | Sell |
|
|||||
|
2021
Q1 | $157M | Sell |
|
|||||
|
2020
Q4 | $231M | Sell |
|
|||||
|
2020
Q3 | $127M | Sell |
|
|||||
|
2020
Q2 | $126M | Buy |
|
|||||
|
2020
Q1 | $73.2M | Buy |
|
|||||
|
2019
Q4 | $197K | Buy |
|